Marco Ladetto
Alessandria, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026
Towards the Definition of a Prognostic Model for Mantle Cell Lymphoma.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International Survey.
Journal: JCO oncology practice
Published: April 27, 2026
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.
Journal: HemaSphere
Published: April 02, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network.
Journal: Lancet (London, England)
Published: December 23, 2025
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.
Journal: HemaSphere
Published: October 10, 2025
VULVO-Vaginal Chronic Graft-Versus-Host Disease Assessment: A Single-Center Prospective Observational Study.
Journal: European journal of haematology
Published: August 26, 2025
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020.
Journal: Haematologica
Published: August 12, 2025
Last Updated: 09/26/2026